Parameters Linked With Higher Itch Severity in Chronic Spontaneous Urticaria—Chronic Urticaria Registry Results

dc.contributor.authorStolz J.
dc.contributor.authorSalameh P.
dc.contributor.authorAsero R.
dc.contributor.authorKocatürk E.
dc.contributor.authorPeter J.
dc.contributor.authorGrattan C.
dc.contributor.authorHerzog L.S.
dc.contributor.authorMuñoz M.
dc.contributor.authorDissemond J.
dc.contributor.authorStaubach-Renz P.
dc.contributor.authorBauer A.
dc.contributor.authorThomsen S.F.
dc.contributor.authorGiménez-Arnau A.M.
dc.contributor.authorPuertolas M.
dc.contributor.authorBocquet A.
dc.contributor.authorMakris M.
dc.contributor.authorGregoriou S.
dc.contributor.authorKhoshkhui M.
dc.contributor.authorKouzegaran S.
dc.contributor.authorvan Doorn M.B.A.
dc.contributor.authorKasperska-Zajac A.
dc.contributor.authorGąsior M.
dc.contributor.authorZając M.
dc.contributor.authorLatysheva E.
dc.contributor.authorFomina D.
dc.contributor.authorKovalkova E.
dc.contributor.authorAndrenova G.
dc.contributor.authorSedova E.
dc.contributor.authorVitchuk A.
dc.contributor.authorBizjak M.
dc.contributor.authorKošnik M.
dc.contributor.authorKulthanan K.
dc.contributor.authorTuchinda P.
dc.contributor.authorDay C.
dc.contributor.authorDeetlefs M.
dc.contributor.authorAulenbacher F.
dc.contributor.authorWeller K.
dc.contributor.authorKolkhir P.
dc.contributor.authorMetz M.
dc.contributor.authorPereira M.P.
dc.contributor.correspondenceStolz J.
dc.contributor.otherMahidol University
dc.date.accessioned2025-07-01T18:16:31Z
dc.date.available2025-07-01T18:16:31Z
dc.date.issued2025-01-01
dc.description.abstractBackground: Itch is the most bothersome symptom in chronic spontaneous urticaria (CSU) and severely affects quality of life. Objective: To analyze factors associated with itch severity, and how itch is associated with quality of life and health care use in CSU. Methods: We retrieved patient data from the Chronic Urticaria Registry. Patients were categorized by self-reported itch severity (recall period of 7 days). We used ordinal logistic regressions as well as negative binomial and gamma regressions with log link to investigate possible associations. Results: A total of 3,045 patients, 74.3% female, mean age 44.4 years, with no, mild, moderate, or intense itch (16.4%, 25.2%, 32.5%, and 25.9%, respectively) were included. A higher itch rating was associated with symptomatic dermographism (odds ratio [OR] = 1.25; P = .027), malaise (OR = 1.43; P < .001), depression (OR = 1.46; P = .008), and laboratory signs of inflammation (ie, elevated erythrocyte sedimentation rate (OR = 1.57; P = .031) and leukocyte counts (OR = 2.37; P = .004)). Intense itch was associated with worse quality of life (Chronic Urticaria Quality of Life Questionnaire; P < .001) and more patients visiting a general practitioner, allergologist or dermatologist, and the emergency room (P < .001). Conclusions: Higher itch levels are associated with inflammation and depression and are linked to worse quality of life and increased health care demand. Addressing itch is crucial to reducing the humanistic and societal burden in CSU.
dc.identifier.citationJournal of Allergy and Clinical Immunology in Practice (2025)
dc.identifier.doi10.1016/j.jaip.2025.05.033
dc.identifier.issn22132198
dc.identifier.pmid40447048
dc.identifier.scopus2-s2.0-105008542645
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/111030
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleParameters Linked With Higher Itch Severity in Chronic Spontaneous Urticaria—Chronic Urticaria Registry Results
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105008542645&origin=inward
oaire.citation.titleJournal of Allergy and Clinical Immunology in Practice
oairecerif.author.affiliationCharité – Universitätsmedizin Berlin
oairecerif.author.affiliationUniversité Grenoble Alpes
oairecerif.author.affiliationErasmus MC
oairecerif.author.affiliationNational and Kapodistrian University of Athens
oairecerif.author.affiliationUniversity of Cape Town
oairecerif.author.affiliationUniversität Duisburg-Essen
oairecerif.author.affiliationSchool of Medicine
oairecerif.author.affiliationSechenov First Moscow State Medical University
oairecerif.author.affiliationUniversitat Pompeu Fabra Barcelona
oairecerif.author.affiliationUniversitätsmedizin Mainz
oairecerif.author.affiliationMashhad University of Medical Sciences
oairecerif.author.affiliationGuy's and St Thomas' NHS Foundation Trust
oairecerif.author.affiliationSlaski Uniwersytet Medyczny w Katowicach
oairecerif.author.affiliationPirogov Russian National Research Medical University (RNRMU)
oairecerif.author.affiliationUniversitätsklinikum Carl Gustav Carus Dresden
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationBispebjerg Hospital
oairecerif.author.affiliationBahçeşehir Üniversitesi
oairecerif.author.affiliationUniverza v Ljubljani Medicinska Fakulteta
oairecerif.author.affiliationBirjand University of Medical Sciences
oairecerif.author.affiliationMoscow Healthcare Department
oairecerif.author.affiliationState Research Center Institute of Immunology FMBA
oairecerif.author.affiliationUniversity of Nicosia Medical School
oairecerif.author.affiliationGilbert and Rose-Marie Chagoury School of Medicine
oairecerif.author.affiliationAstana Medical University
oairecerif.author.affiliationFraunhofer Institute for Translational Medicine and Pharmacology ITMP
oairecerif.author.affiliationCenter for Human Drug Research
oairecerif.author.affiliationSmolensk State Medical Academy
oairecerif.author.affiliationUniversity of Cape Town Lung Institute
oairecerif.author.affiliationInstitut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban
oairecerif.author.affiliationBolnišnica Golnik
oairecerif.author.affiliationClinica San Carlo

Files

Collections